FDA Approves First Radiopharmaceutical for Imaging Tau

For use with PET imaging, the radiopharmaceutical helps estimate density and distribution of tau, a marker of Alzheimer ' s disease.

Source: Diagnostic Imaging - May 29, 2020 Category: Radiology Authors: Matt Hoffman Tags: Alzheimer disease PET/MR Source Type: news